Medical Developments International Limited

Informe acción ASX:MVP

Capitalización de mercado: AU$36.7m

Medical Developments International Dirección

Dirección controles de criterios 3/4

El CEO de Medical Developments International's es Brent MacGregor , nombrado en Nov 2020, tiene una permanencia de 3.42 años. compensación anual total es A$1.94M, compuesta por 29.7% salario y 70.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.029% de las acciones de la empresa, por valor de A$13.63K. La antigüedad media del equipo directivo y de la junta directiva es de 3.7 años y 3.3 años, respectivamente.

Información clave

Brent MacGregor

Chief Executive Officer (CEO)

AU$1.9m

Compensación total

Porcentaje del salario del CEO29.7%
Permanencia del CEO3.5yrs
Participación del CEO0.03%
Permanencia media de la dirección3.8yrs
Promedio de permanencia en la Junta Directiva3.4yrs

Actualizaciones recientes de la dirección

Recent updates

Positive Sentiment Still Eludes Medical Developments International Limited (ASX:MVP) Following 27% Share Price Slump

May 13
Positive Sentiment Still Eludes Medical Developments International Limited (ASX:MVP) Following 27% Share Price Slump

Is Medical Developments International (ASX:MVP) In A Good Position To Invest In Growth?

May 03
Is Medical Developments International (ASX:MVP) In A Good Position To Invest In Growth?

Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge

Mar 11
Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge

Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward

Jan 16
Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward

Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?

Jan 03
Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?

Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Aug 09
Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On Medical Developments International's (ASX:MVP) Cash Burn Rate

Apr 24
We're Keeping An Eye On Medical Developments International's (ASX:MVP) Cash Burn Rate

Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Jul 04
Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Some Analysts Just Cut Their Medical Developments International Limited (ASX:MVP) Estimates

Mar 04
Some Analysts Just Cut Their Medical Developments International Limited (ASX:MVP) Estimates

Medical Developments International Limited (ASX:MVP) Analysts Just Slashed This Year's Estimates

Mar 05
Medical Developments International Limited (ASX:MVP) Analysts Just Slashed This Year's Estimates

If You Had Bought Medical Developments International (ASX:MVP) Shares Five Years Ago You'd Have Earned 56% Returns

Feb 07
If You Had Bought Medical Developments International (ASX:MVP) Shares Five Years Ago You'd Have Earned 56% Returns

Don't Ignore The Fact That This Insider Just Sold Some Shares In Medical Developments International Limited (ASX:MVP)

Dec 16
Don't Ignore The Fact That This Insider Just Sold Some Shares In Medical Developments International Limited (ASX:MVP)

Medical Developments International Limited's (ASX:MVP) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Dec 10
Medical Developments International Limited's (ASX:MVP) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Brent MacGregor en comparación con los beneficios de Medical Developments International?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023n/an/a

-AU$19m

Sep 30 2023n/an/a

-AU$12m

Jun 30 2023AU$2mAU$576k

-AU$6m

Mar 31 2023n/an/a

-AU$4m

Dec 31 2022n/an/a

-AU$2m

Sep 30 2022n/an/a

-AU$7m

Jun 30 2022AU$2mAU$547k

-AU$12m

Mar 31 2022n/an/a

-AU$16m

Dec 31 2021n/an/a

-AU$19m

Sep 30 2021n/an/a

-AU$16m

Jun 30 2021AU$1mAU$351k

-AU$13m

Compensación vs. Mercado: La compensación total de Brent($USD1.26M) está por encima de la media de empresas de tamaño similar en el mercado Australian ($USD290.69K).

Compensación vs. Ingresos: La compensación de Brent ha sido consistente con los resultados de la empresa en el último año.


CEO

Brent MacGregor (59 yo)

3.5yrs

Permanencia

AU$1,941,885

Compensación

Mr. Brent MacGregor serves as an Independent Director at Dynavax Technologies Corporation since July 2020. He has been the Chief Executive Officer of Medical Developments International Limited since Novemb...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Brent MacGregor
Chief Executive Officer3.5yrsAU$1.94m0.029%
A$ 10.6k
Anita James
Chief Financial Officer2yrsAU$505.61ksin datos
Matthew Cramer
Chief of Operations & Supply Chain4.3yrssin datossin datos
Tara Eaton
General Counsel & Company Secretary1.8yrssin datossin datos
Scott Courtney
Chief Scientific Officer4.8yrssin datossin datos
Wai Chi
Head of Regulatory Affairs5.5yrssin datossin datos
Wayne Pearce
Head of Production3.8yrssin datossin datos
Stefaan Schatteman
Head of Europe3.8yrssin datossin datos

3.8yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de MVP se considera experimentado (3.7 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Gordon Naylor
Non-Executive Chairman3.6yrsAU$95.00k1.1%
A$ 404.0k
Mary Sontrop
Non-Executive Director3.2yrsAU$60.00k0.024%
A$ 8.8k
Russell Basser
Non-Executive Directorless than a yearsin datos0.018%
A$ 6.7k
Leon Hoare
Non-Executive Director10.7yrsAU$60.00k0.072%
A$ 26.4k
Richard Betts
Non-Executive Director3yrsAU$60.00k0.027%
A$ 9.9k
Christine Emmanuel-Donnelly
Non-Executive Director4yrsAU$60.00k0.065%
A$ 24.0k

3.4yrs

Permanencia media

Junta con experiencia: La junta directiva de MVP se considera experimentada (3.3 años de antigüedad promedio).